Intraductal Papillary Mucinous Neoplasm Recurrence 10 Years after Duodenopancreatectomy. Laparoscopic Resection (with video) Javier Chinelli, Graciela Hernandez, Carlos Perez, Elisa Laca, Gustavo Rodríguez Video Case Report, Sept 2021 Article DOI: 10.21614/sgo-26-3-361
Pancreatic adenocarcinoma has a poor prognosis, even after R0 resections. Metachronous disease usually arises as distant or regional metastasis, but local recurrence is infrequent. 66 year-old male patient with a subclinical pancreatic remnant lesion suspected to be malignant 10 years after duodenopancreatectomy for invasive mucinous cystoadenocarcinoma. After distant metastatic disease was ruled-out, laparoscopic distal pancreatectomy was performed. Pathology revealed a non-invasive intraductal papillary mucinous neoplasm (IPMN). The decision to resect metachronous disease after pancreatic cancer surgery remains under debate, based on the type of recurrence. Pancreatic remnant lesions can be true recurrences or new primary tumors.
In this case, pathology suggests a slow growth recurrence or a second primary tumor. Patients with local recurrence alone and prolonged disease-free survival like this might benefit from surgical resection. This case highlights the importance of long-term follow-up of malignant pancreatic cystic tumors, as surgical treatment of local recurrences could be potentially curative.
In the present case this was achieved successfully through a technically challenging minimally invasive approach.
Surgery, Gastroenterology and Oncology (SGO) is indexed in:
SCOPUS
EBSCO
DOI/Crossref
Google Scholar
SCImago
Harvard Library
Open Academic Journals Index (OAJI)
Open Access Statement
Surgery, Gastroenterology and Oncology (SGO) is an open-access, peer-reviewed online journal published by Celsius Publishing House. The journal allows readers to read, download, copy, distribute, print, search, or link to the full text of its articles.
Journal Metrics
Time to first editorial decision: 25 days
Rejection rate: 61%
CiteScore: 0.2
Surgery, Gastroenterology and Oncology applies the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits readers to copy and redistribute the material in any medium or format, remix, adapt, build upon the published works non-commercially, and license the derivative works on different terms, provided the original material is properly cited and the use is non-commercial. Please see: https://creativecommons.org/licenses/by-nc/4.0/
Publisher’s Note:
The opinions, statements, and data contained in article are solely those of the authors and not of Surgery, Gastroenterology and Oncology journal or the editors. Publisher and the editors disclaim responsibility for any damage resulting from any ideas, instructions, methods, or products referred to in the content.